BriaCell Therapeutics Corp.
BCTX · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $21 | $14 | $83 | $136 |
| - Cash | $3 | $10 | $17 | $7 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $18 | $4 | $66 | $128 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$11 | -$9 | -$9 |
| % Margin | – | – | – | – |
| Net Income | -$11 | -$11 | -$9 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.31 | -5.87 | -23.33 | -33.57 |
| % Growth | 26.6% | 74.8% | 30.5% | – |
| Operating Cash Flow | -$11 | -$11 | -$10 | -$9 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$11 | -$11 | -$10 | -$9 |